Myriad Genetics Inc (NASDAQ:MYGN)

33.97
Delayed Data
As of Jul 06
 -0.60 / -1.74%
Today’s Change
31.34
Today|||52-Week Range
40.50
-0.26%
Year-to-Date

Today’s Trading

Previous close34.57
Today’s open34.27
Day’s range-- - --
Volume2,037,194
Average volume (3 months)798,458
Market cap$2.4B
Dividend yield--
Data as of 07/06/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-40.01%
Earnings growth (next 5 years)+13.17%
Revenue growth (last year)+26.92%
P/E ratio27.1
Price/Sales3.42
Price/Book3.53

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Healthcare...-0.03-0.04%
--COSMO Pharmaceutical...+1.20+0.75%
INSYINSYS Therapeutics I...+1.00+2.82%
TSROTESARO Inc+0.85+1.52%
Data as of 07/06/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers